Analyst Ratings for Express Scripts (ESRX) [Buys]
ESRX Rating Summary
ESRX Price Target Summary
- Highest: $74.00 (Jefferies)
- Lowest: $52.00 (Deutsche Bank)
- Average: $65.12
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$65.12 (+3.5%)
Avg. $ Target:
$65.12 (+3.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2013 | Jefferies | Upgrade | Buy (Hold) |
74.00 (56.00) |
61.40 | 62.94 | 2.51% | Details |
| 7/17/2012 | JMP Securities | New Coverage | Market Outperform (N/A) |
66.00 (N/A) |
57.75 | 62.94 | 8.99% | Details |
| 4/4/2012 | Lazard Capital | New Coverage | Buy (N/A) |
67.00 (N/A) |
57.67 | 62.94 | 9.14% | Details |
| 4/3/2012 | JPMorgan | New Coverage | Overweight (N/A) |
69.00 (N/A) |
55.50 | 62.94 | 13.41% | Details |
| 4/3/2012 | Goldman Sachs | New Coverage | Conviction Buy (N/A) |
70.00 (N/A) |
55.50 | 62.94 | 13.41% | Details |
| 10/4/2011 | Oppenheimer » Updated 12/14/2011 |
New Coverage | Outperform (N/A) |
54.00 (N/A) |
35.71 | 62.94 | 76.25% | Details |
| 8/15/2011 | BB&T Capital | Upgrade | Buy (N/A) |
66.00 (N/A) |
46.69 | 62.94 | 34.8% | Details |
| 7/22/2011 | Maxim Group | Upgrade | Buy (N/A) |
69.00 (N/A) |
55.36 | 62.94 | 13.69% | Details |
| 5/25/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
59.28 | 62.94 | 6.17% | Details |
| 10/26/2010 | RBC Capital | New Coverage | Outperform (N/A) |
N/A (N/A) |
49.10 | 62.94 | 28.19% | Details |
